go back

Brexucabtagene Autoleucel (Tecartus)

Iowa rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $645,654 · 10th to 90th $645,654 to $645,654Professionalmedian $977,237 · 10th to 90th $977,237 to $977,237
$1Mfacility $645,654professional $977,237

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Medica
Setting
Facility
Modifier
Global
Typical Low
$645,654.23
Median
$645,654.23
Typical High
$645,654.23
Medica
Setting
Professional
Modifier
Global
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22